3-methylcholanthrene has been researched along with busulfan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Hosokawa, M; Kobayashi, H; Mizukoshi, T; Sugawara, M | 1 |
| Claus-Walker, J | 1 |
| Ehrhart, H; Schwandt, P | 1 |
4 other study(ies) available for 3-methylcholanthrene and busulfan
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice.
Topics: Adjuvants, Immunologic; Animals; Busulfan; Female; Methylcholanthrene; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proteoglycans; Sarcoma, Experimental | 1985 |
Hypothyroidism induced by a transplanted fibrosarcoma in the rat.
Topics: Animals; Body Weight; Busulfan; Cyclophosphamide; Fibrosarcoma; Hypothyroidism; Male; Methylcholanthrene; Neoplasm Transplantation; Organ Size; Pituitary Gland; Rats; Sarcoma, Experimental; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Tissue Extracts | 1967 |
NAD, ATP and lipid contents in normal and leukemic human leukocytes, before and after cytostatic therapy.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Busulfan; Cholesterol; Cyclophosphamide; Fatty Acids; Glycolysis; Humans; Imides; Leukemia, Experimental; Leukemia, Myeloid; Leukocytes; Lipids; Methylcholanthrene; NAD; Neoplasm Transplantation; Phospholipids; Rats; Time Factors; Urea | 1972 |